Search / Trial NCT06222554

Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients

Launched by NYU LANGONE HEALTH · Jan 16, 2024

Trial Information

Current as of December 30, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new exercise program called MoveMend Health, designed to help patients recovering from kidney or liver transplants while they are in the hospital. The goal is to see how well this program works alongside regular occupational therapy, which is a type of treatment that helps people regain their ability to perform daily activities. Researchers want to find out if patients can easily use the program, how many patients sign up for it, and what feedback they give about their experience.

To be eligible for this study, participants should be English-speaking adults aged 65 to 74 who have recently undergone a kidney or liver transplant and have been ordered by their doctor to receive occupational therapy. They should also be alert and not show signs of confusion. However, individuals with severe shoulder injuries or certain other medical conditions that limit their movement may not be able to participate. Those who join can expect to use the MoveMend program in addition to their regular therapy sessions, and their experiences will help researchers understand how beneficial this new approach could be for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • English speaking (software program is currently only available in English)
  • Status post kidney or liver transplant this admission
  • Physician orders for occupational therapy evaluation and treatment
  • Orientation Log \> 25
  • Negative for delirium per the Confusion Assessment Method
  • Exclusion Criteria:
  • Orthopedic or surgical precautions that limits shoulder range of motion beyond 90 degrees
  • Upper extremity hemiplegia with inability to lift upper extremity against gravity
  • Accommodation code of Intensive Care Unit

Trial Officials

Steve Vanlew

Principal Investigator

NYU Langone Health

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0